Home/Filings/4/0001104659-24-043111
4//SEC Filing

Ferguson Toby 4

Accession 0001104659-24-043111

CIK 0001640266other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:17 PM ET

Size

5.7 KB

Accession

0001104659-24-043111

Insider Transaction Report

Form 4
Period: 2024-04-01
Ferguson Toby
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-04-01+105,000105,000 total
Footnotes (2)
  • [F1]This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
  • [F2]Consists of shares of common stock underlying a restricted stock unit ("RSU") award. Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is April 1, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting upon the one-year anniversary of such vesting commencement date and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued service as an employee.

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0002015616

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:17 PM ET
Size
5.7 KB